Filter Results :

Your search for Diseases returned 193 reports

Sort by


2015 Opportunities in the German Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 280-page report from Venture Planning Group presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume a...

$ 1,950.00

Read More

2015 Opportunities in the French Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report pro...

$ 1,950.00

Read More

2015 Opportunities in the European Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  The repor...

$ 7,900.00

Read More

2015 Opportunities in the Global Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 350-page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading supplie...

$ 9,600.00

Read More

2015 Opportunities in the Global Respiratory Diseases Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 366-page report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. ...

$ 9,850.00

Read More

2015 Opportunities in the US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 280-page report from Venture Planning Group presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and s...

$ 3,450.00

Read More

2015 Opportunities in the UK Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and s...

$ 1,950.00

Read More

2015 Opportunities in the Spanish Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume ...

$ 1,950.00

Read More

2015 Opportunities in the Italian Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

22 Apr 2015  |  Published by:  VPG Market Research
 This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test ...

$ 1,950.00

Read More

Motor Neurone Diseases-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Motor Neurone Diseases-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Motor Neurone Diseases. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Motor Neur...

$ 1,250.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Inflammatory Skin Diseases-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Inflammatory Skin Diseases. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under In...

$ 1,250.00

Read More

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Graves Diseases-API Insights, 2015,report provides Graves Diseases drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00

Read More

Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019

19 Mar 2015  |  Published by:  MarketsandMarkets
The global metabolic testing market is expected to reach $475.75 million by 2019 from $332.78 million in 2014, growing at a CAGR of 7.41% between 2014 and 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014–2019). Moreover...

$ 4,650.00

Read More

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

11 Mar 2015  |  Published by:  Technavio
About Acquired Orphan Blood Diseases TherapeuticsAcquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically because of the improper functioning of bone marrow to produce RBCs in the blood. This leads to a ...

$ 3,000.00

Read More

U.S. Army Medical Research Institute of Infectious Diseases - Medical Equipment - Deals and Alliances Profile

10 Feb 2015  |  Published by:  GlobalData
SummaryU.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is a pharmaceutical and healthcare service provider. The company develops medical solutions, vaccines, drugs, diagnostics, and information. It conducts research activities on infectious diseases. USAMRIID protects both mil...

$ 250.00

Read More
Total 193 records.